COMPASS THERAPEUTICS INC's ticker is CMPX and the CUSIP is 20454B104. A total of 78 filers reported holding COMPASS THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $57 | -62.0% | 57,631 | -24.1% | 0.00% | – |
| Q1 2024 | $150 | -23.5% | 75,913 | -39.5% | 0.00% | – |
| Q4 2023 | $196 | +232.2% | 125,486 | +314.1% | 0.00% | – |
| Q3 2023 | $59 | -41.6% | 30,303 | -5.1% | 0.00% | – |
| Q2 2023 | $101 | -24.6% | 31,921 | -22.1% | 0.00% | – |
| Q1 2023 | $134 | +47.3% | 40,986 | +124.9% | 0.00% | – |
| Q4 2022 | $91 | -90.9% | 18,225 | +4773.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Owl Capital Holdings LP | 2,829,712 | $2,829,712 | 0.79% |
| MPM BioImpact LLC | 5,005,086 | $5,005,086 | 0.78% |
| Orbimed Advisors | 22,362,850 | $22,362,850 | 0.44% |
| Vivo Capital, LLC | 3,556,023 | $3,556,023 | 0.33% |
| CM Management, LLC | 310,000 | $310,000 | 0.28% |
| CAXTON CORP | 43,465 | $43,465 | 0.22% |
| Rock Springs Capital Management LP | 5,513,788 | $5,513,788 | 0.17% |
| Cormorant Asset Management, LP | 2,030,823 | $2,030,823 | 0.12% |
| Ground Swell Capital, LLC | 124,394 | $124,394 | 0.10% |
| Monashee Investment Management LLC | 500,000 | $500,000 | 0.06% |